Fresenius Kabi Deutschland Gmbh
🇸🇪Sweden
Clinical Trials
43
Active:34
Completed:6
Trial Phases
3 Phases
Phase 1:23
Phase 3:1
Not Applicable:6
Drug Approvals
142
NMPA:71
CIMA_AEMPS:39
SFDA:16
+2 more agencies
Drug Approvals
Linezolid and Glucose Injection
- Product Name
- 利奈唑胺葡萄糖注射液
- Approval Number
- 国药准字HJ20240040
- Approval Date
- Jun 11, 2024
NMPA
Multi-trace Elements Injection (III)
- Product Name
- 多种微量元素注射液(Ⅲ)
- Approval Number
- 国药准字HJ20210060
- Approval Date
- Jul 20, 2021
NMPA
Propofol Medium and Long Chain Fat Emulsion Injection
- Product Name
- 丙泊酚中/长链脂肪乳注射液
- Approval Number
- 国药准字HJ20150657
- Approval Date
- Aug 21, 2020
NMPA
Propofol Medium and Long Chain Fat Emulsion Injection
- Product Name
- 丙泊酚中/长链脂肪乳注射液
- Approval Number
- 国药准字HJ20150659
- Approval Date
- Aug 17, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
Clinical Trials
Distribution across different clinical trial phases (30 trials with phase data)• Click on a phase to view related trials
Phase 1
23 (76.7%)Not Applicable
6 (20.0%)Phase 3
1 (3.3%)No trials found
News
No news found